We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Visual description of the abdominal aortic aneurysm (AAA) screening pathway.
Executive summary of quality assurance (QA) visit to West Hertfordshire NHS Hospitals Trust held in November 2016.
Executive summary of quality assurance (QA) visit to Sussex held on 22 February 2018.
Data report for abdominal aortic aneurysm (AAA) screening for 1 April 2021 to 31 March 2022.
Information for men who have a medium abdominal aortic aneurysm detected through screening.
Executive summary of quality assurance (QA) visit to University Hospitals of Leicester NHS Trust abdominal aortic aneurysm screening service on 12 February 2019.
Information for men who have a small aneurysm detected through screening.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
This information can help healthcare professionals speak with people, following suspected or confirmed diagnosis of gastroschisis.
Executive summary of quality assurance (QA) visit to South Devon and Exeter held on 17 January 2019.
Executive summary of quality assurance (QA) visit to North London held on 28 February 2019.
This guidance has been produced in collaboration with the UK Kidney Patient Safety Committee (KPSC), to summarise known safety issues with dialysis and continuous renal replacement therapy (CRRT) and describe what to do to minimise or prevent serious injury.
Executive summary of quality assurance (QA) visit to North West London held on 26 September 2017.
Executive summary of quality assurance (QA) visit to Dorset and Wiltshire held on 18 April 2018.
Executive summary of quality assurance (QA) visit to South Yorkshire and Bassetlaw abdominal aortic aneurysm screening programme held on 15 March 2018.
Guidance for providers of abdominal aortic aneurysm (AAA) screening on non-visualised screening results.
Information on managing and monitoring a large abdominal aortic aneurysm (AAA) identified through screening.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).